Immune Checkpoint Inhibitors for Classical Hodgkin Lymphoma in Brentuximab Vedotin-naive Patients: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines.
Williams D, Gray C, Picheca L.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun 21.
PMID:31503428
Composite lymphoma of peripheral T-cell lymphoma and Hodgkin lymphoma, mixed cellularity type; pathological and molecular analysis.
Ichikawa A, Miyoshi H, Yamauchi T, Arakawa F, Kawano R, Muta H, Sugita Y, Akashi K, Ohshima K.
Pathol Int. 2017 Apr;67(4):194-201. doi: 10.1111/pin.12515. Epub 2017 Feb 13.